These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11364278)

  • 1. More pharmacies to carry Crixivan.
    GMHC Treat Issues; 1997 Mar; 11(3):8-9. PubMed ID: 11364278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indinavir (Crixivan) becoming available at many pharmacies.
    AIDS Treat News; 1997 May; (No 271):5. PubMed ID: 11364369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indinavir (Crixivan) access and distribution.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):3-5. PubMed ID: 11363304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting your space on the magic crixi-van.
    Gilden D
    GMHC Treat Issues; 1996 Mar; 10(3):4. PubMed ID: 11363390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merck protease inhibitor available to persons with CD4 count 50 or less--must register by August 11.
    AIDS Treat News; 1995 Jul; (no 227):1-2. PubMed ID: 11362618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merck expanded access program August 11, 1995 deadline.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merck discontinues twice-daily dosing of Crixivan.
    Res Initiat Treat Action; 1998 Oct; 4(6):13. PubMed ID: 11365914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merck's protease inhibitor expanded access program now open.
    Smart T; Torres G
    GMHC Treat Issues; 1995; 9(7/8):10. PubMed ID: 11362649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Merck-Stadtlanders distribution agreement for Crixivan.
    Nary G
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):52-3. PubMed ID: 11363520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Europeans outraged over expanded access.
    Alcorn K; Nary G; Pernet AG; Surchio JL; Weiner JD
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):48-51. PubMed ID: 11363519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-daily dosing Crixivan study discontinued.
    WORLD; 1998 Oct; (No 90):7. PubMed ID: 11365922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merck announces compassionate-treatment lottery for Crixivan.
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):38. PubMed ID: 11362730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir (Crixivan): new packaging and strength.
    Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crixivan warning: keep to three times a day.
    Gilden D
    GMHC Treat Issues; 1998 Sep; 12(9):2. PubMed ID: 11365805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-a-day Crixivan study discontinued.
    Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underground protease inhibitor.
    GMHC Treat Issues; 1995 Jan; 9(1):2. PubMed ID: 11367379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded access programs expanding.
    Proj Inf Perspect; 1997 Nov; (23):20-1. PubMed ID: 11365376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice daily Indinavir trial stopped.
    TreatmentUpdate; 1998 Oct; 10(8):3-4. PubMed ID: 11365875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical alert: hemolytic anemia in Crixivan cohort.
    Crit Path AIDS Proj; 1997; (No 32):28-9. PubMed ID: 11364438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.